We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
The interplay of ferroptosis and oxidative stress in pulmonary fibrosis: from mechanisms to treatment
Summary
This research review summarizes how a specific type of cell death called ferroptosis may contribute to pulmonary fibrosis, a serious lung disease where scar tissue builds up and makes breathing difficult. Scientists have found that when cells die from iron buildup and damage from harmful molecules, it can worsen lung scarring, but drugs that block this process show promise in animal studies. Understanding this connection could lead to new treatments for people with pulmonary fibrosis, though more research is needed to make sure these potential medicines are safe and effective in humans.
Pulmonary fibrosis (PF) is a progressive and devastating interstitial lung disease characterized by the dynamic imbalance of multiple cell types and signaling pathways. In recent years, ferroptosis, an iron-dependent form of programmed cell death driven by lipid peroxidation, has been recognized as playing a significant role in the progression of pulmonary fibrosis due to its central role in oxidative stress, metabolic dysfunction, and disruption of barrier integrity. Existing studies have elucidated the core signaling pathways, key molecules, and potential roles of ferroptosis in PF progression, highlighting the synergistic pathogenic effects of iron homeostasis disruption and lipid peroxidation. Despite its established role in fibrosis, a comprehensive analysis of the cell-type-specific mechanisms of ferroptosis within pulmonary cell populations remains lacking. Furthermore, several small-molecule inhibitors targeting ferroptosis have demonstrated promising anti-fibrotic effects in animal models, yet their tissue-specificity, safety profiles, and clinical feasibility warrant further investigation. This review systematically summarizes the cell-type-specific roles of ferroptosis in PF, delineates the key molecular mechanisms and potential druggable targets involved, and underscores the potential of ferroptosis as a critical regulatory node at the intersection of metabolism and cell fate. By bridging the understanding of metabolic regulation and cell death processes, ferroptosis holds promise for providing novel mechanistic insights and informing precise therapeutic strategies for pulmonary fibrosis.
Sign in to start a discussion.
More Papers Like This
Ferritinophagy Mediated by Oxidative Stress-Driven Mitochondrial Damage Is Involved in the Polystyrene Nanoparticles-Induced Ferroptosis of Lung Injury
Researchers found that inhaled polystyrene nanoplastics cause lung damage through a specific cell death process called ferroptosis, which involves iron buildup and oxidative stress in lung cells. The nanoplastics damaged mitochondria and triggered a chain reaction where the cell's iron storage was broken down, releasing harmful iron. Blocking this ferroptosis process with a drug called ferrostatin-1 reversed the lung damage in mice, pointing to a potential treatment approach.
Targeting Regulated Cell Death Pathways in COPD: Mechanisms and Therapeutic Strategies
This review examines how multiple regulated cell death pathways — including apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy — contribute to chronic obstructive pulmonary disease progression and discusses these pathways as potential therapeutic targets.
Polystyrene nanoplastics-induced lung epithelial cells ferroptosis promotes pulmonary fibrosis via YY1/FTL axis
Researchers found that polystyrene nanoplastics induced ferroptosis—an iron-dependent form of cell death—in lung bronchial epithelial cells and promoted pulmonary fibrosis in mice via the YY1/FTL signaling axis. The study identified ferroptosis as a novel mechanism underlying nanoplastic-induced lung injury and fibrosis, with potential therapeutic relevance for targeting this pathway.
Ferroptosis of smooth muscle cells in vascular diseases: from basic principles to clinical translation
Scientists have discovered that smooth muscle cells in blood vessels can die through a process called "ferroptosis" - a type of cell death caused by iron buildup and toxic fats. This review of existing research shows that this cell death process contributes to many serious heart and blood vessel diseases, including atherosclerosis, high blood pressure, and aneurysms. Understanding how this happens could lead to new treatments that protect blood vessels and reduce the risk of heart attacks and strokes.
Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: Existing evidence and future directions
This review explores the relationship between the protein GSTP1, ferroptosis (a form of iron-dependent cell death), and radiotherapy resistance in lung cancer. Researchers propose that targeting GSTP1 could help overcome tumor cell resistance to radiation by promoting ferroptosis. While focused on cancer treatment mechanisms, the study touches on how environmental factors and oxidative stress pathways relevant to pollutant exposure intersect with cellular defense mechanisms.